Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | — | 1 | — | — | — | 1 |
Non-small-cell lung carcinoma | D002289 | — | — | — | 1 | — | — | — | 1 |
Skin neoplasms | D012878 | EFO_0004198 | C44 | — | 1 | — | — | — | 1 |
Melanoma | D008545 | — | — | — | 1 | — | — | — | 1 |
Microsatellite instability | D053842 | — | — | — | 1 | — | — | — | 1 |
Cutaneous malignant melanoma | D000096142 | — | — | — | 1 | — | — | — | 1 |
Drug common name | Vusolimogene oderparepvec |
INN | vusolimogene oderparepvec |
Description | Vusolimogene oderparepvec is a gene pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Gene |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4650271 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 45KLN7N6UV (ChemIDplus, GSRS) |